UNSPSC 85251605: Diagnosis of malignant neoplasm on the middle third of oesophagus

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Middle third of oesophagus. Malignant neoplasm on the Middle third of oesophagus is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C15. 4

UNSPSC 85251605 Diagnosis of malignant neoplasm on the middle third of oesophagus, a Commodity code, shows little relevant recent activity under state and local procurement. The three recent opportunities posted under this code—a diagnostic imaging PACS system upgrade at San Mateo Medical Center, special education contracted services at Birdville Independent School District, and temporary health professional staffing for Santa Clara Health System—do not align with the code's nominal scope of clinical diagnosis services for esophageal malignancy. San Mateo's opportunity concerns enterprise-grade imaging infrastructure migration and implementation rather than diagnostic pathology or oncology consultation; Birdville's scope is educational support services unrelated to medical diagnosis; and Santa Clara's solicitation addresses temporary clinical staffing across multiple ancillary categories including radiology, audiology, and therapy services, not esophageal cancer diagnosis specifically.

The geographic distribution spans California (San Mateo County and Santa Clara County health systems) and Texas (Tarrant County school district), but these jurisdictions are pursuing procurement in medical infrastructure, education support, and general clinical staffing—categories that do not map to the code's stated purpose. The code appears misapplied by the issuing bodies, suggesting either data quality issues in UNSPSC tagging or a mismatch between the code's clinical intent and how state and local procurement systems classify health system technology and staffing contracts. Firms seeking genuine opportunities in esophageal cancer diagnosis or related oncology services should verify code assignment before investing in pursuit.